IL6 and infection: MRS-produced LC04 CFS at 20% slightly counteracted infection-induced inflammation but still significantly increased IL-6 levels compared to the infection control (p < 0.0001; Figure 4e), while vitamin D significantly reduced this effect (p < 0.0001), bringing IL-6 levels to those seen during infection.